CLINICAL_TRIALS
trial_result
· 2016-07-28
Clinical Trial Update: Phase II Study of Pemetrexed in Advanced or Recurrent Gastric Cancer After Chemotherapy [Phase 2]
Summary
A Phase II study evaluating pemetrexed in patients with advanced or recurrent gastric cancer after prior chemotherapy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sun Yat-sen University | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED